Prolonged therapy with the fusion inhibitor T-20 in combination with oral antiretroviral agents in an HIV-infected individual [3]

AIDS

Volumn 13, Issue 15, 1999, Pages 2171-2173

  Pilcher, C D ^a   Eron J J , Jr ^a   Ngo, L ^a   Dusek, A ^a   Sista, P ^a   Gleavy, J ^a   Brooks, D ^a   Venetta, T ^a   DiMassimo, E ^a   Hopkins, S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ENFUVIRTIDE; NELFINAVIR; NEVIRAPINE; SAQUINAVIR; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; MIDDLE AGED; NELFINAVIR; NEVIRAPINE; PEPTIDES; REVERSE TRANSCRIPTASE INHIBITORS; SAQUINAVIR;

EID: 0032750956     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199910220-00024     Document Type: Letter

References (5)